Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 Cases with a study of cross-reactions between synergistins

Contact Dermatitis

Volumn 50, Issue 1, 2004, Pages 22-26

  Barbaud, A ^a,b   Trechot, P ^a   Weber Muller, F ^a   Ulrich, G ^a   Commun, N ^a   Schmutz, J L ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b Dermatology Department   (France)

Author keywords

Cutaneous adverse drug reaction; Dalfopristin quinupristin; Drug intradermal tests; Drug patch tests; Drug prick tests; Pristinamycin; Synergistin antibiotics; Virginiamycin

Indexed keywords

DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; DEPSIPEPTIDE; MACROLIDE; PRISTINAMYCIN; QUINUCLIDINE DERIVATIVE; QUINUPRISTIN; VIRGINIAMYCIN;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CHEMICAL STRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC VALUE; ERYTHRODERMA; FEMALE; HUMAN; MALE; ONSET AGE; PATCH TEST; PRICK TEST; RASH; SKIN TEST; STEVENS JOHNSON SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CROSS REACTIONS; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRISTINAMYCIN; RETROSPECTIVE STUDIES; SKIN TESTS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRGINIAMYCIN;

EID: 1842844328     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-1873.2004.00280.x     Document Type: Article

References (7)

1. Moore N, Paux G, Begaud B, Biour M, Loupi E, Boismare F, Royer RJ. Adverse drug reaction monitoring: doing it the French way. Lancet 1985: ii: 1056-1058.
2. Barbaud A, Goncalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001: 45: 321-328.
3. Bernard P, Fayol J, Bonnafoux A, Bedane C, Delrous JL, Catanzano G, Bonnetblanc JM. Toxidermies après prise orale de pristinamycine. Ann Dermatol Venereol 1988: 115: 63-66.
4. Barbaud A, Bene M C, Reichert-Pénétrat S, Jacquin-Petit MA, Schmutz JL, Faure GC. Immunocompetent cells and adhesion molecules in 14 cases of cutaneous drug reactions induced by antibiotics. Arch Dermatol 1998: 134: 1040-1041.
5. Michel M, Dompmartin A, Szczurko C, Castel B, Moreau A, Leroy D. Eczematous-like drug eruption induced by synergistins. Contact Dermatitis 1996: 34: 86-87.
6. Mayence C, Dompmartin A, Verneuil L, Michel M, Leroy D. Value of patch tests in pristinamycin-induced drug eruptions. Contact Dermatitis 1999: 40: 161-162.
7. Barbaud A, Reichert-Penetrat S, Trechot P et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998: 139: 49-58.